Study: Cannabidiol-Based Medication Reduces Intense Seizures by 50%

The following excerpt is from an article that originally appeared on Natural Society

Marijuana has been associated with reducing seizures in people with epilepsy for years, but only now is the topic getting more of the scientific scrutiny it deserves. In a recent study, cannabidiol (CBD) reduced the number of seizures by half in a substantial number of children and adults with Lennox-Gastaut syndrome (LGS), a severe form of epilepsy.

GW Pharmaceuticals, a developer of cannabidiol, sponsored the study.

In a press release, study author Dr. Anup Patel, of Nationwide Children’s Hospital and The Ohio State University College of Medicine in Columbus and a member of the American Academy of Neurology, said:

“Our study found that cannabidiol shows great promise in that it may reduce seizures that are otherwise difficult to control. This is important because this kind of epilepsy is incredibly difficult to treat.”

Tracking the Effect of CBD on Seizures

For the study, researchers followed 225 people with LGS for 14 weeks. The participants had an

Click here to Read this Entire Story on Natural Society


This post was originally published on this site
Comments are closed.